The Valley Desk

Clinical trial reportNeuro-oncologyPublished

Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Neuro-oncology
Published
Subject terms
Humans; Optic Nerve Glioma; Neoplasm Recurrence, Local; Proto-Oncogene Proteins B-raf; Protein Kinase Inhibitors; Prognosis; Follow-Up Studies; Visual Acuity; Drug Resistance, Neoplasm; Adolescent; Child; Child, Preschool
PubMed ID
39700439
PubMed Central ID
PMC12187376
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal